We are excited to welcome @Nina_Dudnik in the newly created role as Chief Business Officer @biolabs. Nina will help lead @biolabs in a period of rapid growth & expansion including our international sites starting w @BioLabsFR & #Heidelberg@BioRNCluster
https://t.co/uioIRsOTQR
A BIG thank you to Melissa K. and Sarah W. @NEBiolabs for presenting their #NEBnow freezer program. Our members are so grateful for the ability to resource reagents on demand for all of their research needs.
#EnablingAwesome one reagent at a time!
Does your emerging #biopharma have an innovative #oncology treatment in the pipeline? On July 21, @Bayer Regulatory Affairs experts will share their experiences navigating the US @FDA approval process and offer insights and advice. Register for free: https://t.co/L75IqBTZad
Congratulations to the winner of our San Diego Innovation Prize - EnAble Therapeutics! They are developing novel therapeutics utilizing Cross-Corrective Gene Therapy for 'unreachable' CNS Disorders. The Prize gives them one year of free bench space at @BioLabsHQ. #Innovation
Calling all early stage #biotechstartups working on #newtargetconcepts or #drugdiscovery.Boehringer Ingelheim Innovation Prize is providing one bench to a current/interested company here at BioLabs San Diego #coworkingspace. See below for details on how to submit your application
Congratulations to our @biolabs resident company @spinogenix who was just granted FDA Orphan Drug Designation for SPG302 for the Treatment of Amyotrophic Lateral Sclerosis! #Biotechnology#BiotechNews
https://t.co/mTjuOhMsPX
This month's members only #InsidersCircle is hosting Dan Oliver, CEO and Co-Founder of Rejuvenate Bio, a graduate from our location in San Diego as well as Adam Milne, COO at BioLabs! Sharing #innovation, #adaptation and #expereince to help support a growing BioLabs ecosystem.
Congratulations to one of BioLabs San Diego's alumni, @BluestarGenomic for $70M Series C, we are so excited for what's to come! Well done to you and your team
And there's "one more thing"... we are pleased to announce our last Series A financing from PXV Fund I: Juno Diagnostics, an exciting diagnostics platform w/ a lead program in NIPT (non-invasive prenatal testing)! Congrats to CEO Dirk van den Boom & team! https://t.co/Jp7qjK4zTD
@biolabs is excited to invite our members to the new virtual series Insiders Circle! These candid discussions will give our resident companies across the @biolabs network a chance to connect and share insights into their experiences as #lifescience#startups.
We are so grateful to remain open during these difficult times and continue welcoming and supporting new companies to our San Diego location.
Welcome SNO bio, VersaPeutics and Multiverse to BioLabs. We are excited to see what you can accomplish!